Kloner R A, Shook T, Przyklenk K, Davis V G, Junio L, Matthews R V, Burstein S, Gibson M, Poole W K, Cannon C P
Columbia Presbyterian Medical Center, New York, N.Y.
Circulation. 1995 Jan 1;91(1):37-45. doi: 10.1161/01.cir.91.1.37.
Ischemic preconditioning has been shown to reduce myocardial infarct size in experimental models, but its role in patients remains unclear. Angina before myocardial infarction reflects brief episodes of ischemia and may be a marker of preconditioning. As part of the Thrombolysis in Myocardial Infarction (TIMI) 4 study, we performed an analysis on the effect of a history of previous angina on in-hospital outcomes for patients with acute myocardial infarction.
Patients eligible for thrombolytic therapy were enrolled into the study. Data were collected from case report forms regarding previous history of angina, in-hospital outcome and 6-week follow-up. Two hundred eighteen patients had a history of previous angina at any time before acute myocardial infarction, and 198 patients did not have previous angina. Patients with any previous history of angina were less likely than with those without angina to experience in-hospital death (3% versus 8%) (P = .03), severe congestive heart failure (CHF) or shock (1% versus 7%, P = .006), or the combined end point of in-hospital death, severe CHF, or shock (4% versus 12%, P = .004). Moreover, patients with any history of angina were more likely to have a smaller creatine kinase (CK)-determined infarct size (119 versus 154 CK integrated units; P = .01) and were less likely to have Q waves on their ECG (57% versus 69%; P = .01). In the subset of patients who experienced angina within the 48 hours before infarction (compared with those who did not), there was a trend toward less likely in-hospital death (3% versus 6%; P = .09), a lower incidence of severe CHF or shock (1% versus 6% P = .008), a lower combined end point of death, CHF, or shock (3% versus 10%; P = .006), smaller infarct size assessed by CK (115 versus 151 CK units; P = .03), and a trend toward fewer Q-wave infarcts. However, patients with a history of previous angina did have a trend toward more recurrent ischemic pain. Of importance is that the beneficial in-hospital effects of previous angina were not dependent on angiographically visible coronary collaterals.
Previous angina confers a beneficial effect on in-hospital outcome after acute myocardial infarction. The reasons for this benefit are uncertain, but one potential mechanism for this observation may be ischemic preconditioning.
缺血预处理已被证实在实验模型中可减小心肌梗死面积,但其在患者中的作用仍不明确。心肌梗死前的心绞痛反映了短暂的缺血发作,可能是预处理的一个标志。作为心肌梗死溶栓(TIMI)4研究的一部分,我们对既往有过心绞痛病史对急性心肌梗死患者住院结局的影响进行了分析。
符合溶栓治疗条件的患者被纳入研究。从病例报告表中收集有关既往心绞痛病史、住院结局及6周随访的数据。218例患者在急性心肌梗死前的任何时间有过心绞痛病史,198例患者无既往心绞痛病史。有任何既往心绞痛病史的患者比无心绞痛病史的患者更不容易发生住院死亡(3%对8%)(P = 0.03)、严重充血性心力衰竭(CHF)或休克(1%对7%,P = 0.006),或住院死亡、严重CHF或休克的联合终点(4%对12%,P = 0.004)。此外,有任何心绞痛病史的患者更有可能有肌酸激酶(CK)测定的梗死面积较小(119对154 CK积分单位;P = 0.01),且心电图上出现Q波的可能性较小(57%对69%;P = 0.01)。在梗死前48小时内发生心绞痛的患者亚组中(与未发生者相比),有住院死亡可能性降低的趋势(3%对6%;P = 0.09)、严重CHF或休克的发生率较低(1%对6%,P = 0.008)、死亡、CHF或休克的联合终点较低(3%对10%;P = 0.006)、CK评估的梗死面积较小(115对151 CK单位;P = 0.03),以及Q波梗死较少的趋势。然而,有既往心绞痛病史确实有复发性缺血性疼痛增加的趋势。重要的是,既往心绞痛的有益住院效应并不依赖于血管造影可见的冠状动脉侧支循环。
既往心绞痛对急性心肌梗死后的住院结局有有益影响。这种益处的原因尚不确定,但这一观察结果的一个潜在机制可能是缺血预处理。